Utility of the dipstick micraltest II™ in the screening of microalbuminuria of diabetes mellitus type 2 and essential hypertension

Revista de Investigacion Clinica

Volumn 58, Issue 3, 2006, Pages 190-197

  Cortés Sanabria, Laura ^a   Martínez Ramírez, Héctor R ^b   Hernández, José L ^a   Rojas Campos, Enrique ^c   Canales Muñoz, José L ^c   Cueto Manzano, Alfonso M ^c  

^a Delegación Jalisco ^*  (Mexico)

^b Dirección de Educación e Investigación en Salud   (Mexico)

^c HOSPITAL DE ESPECIALIDADES   (Mexico)

Author keywords

Diabetes mellitus 2; Early nephropathy; Essential hypertension; Micraltest ; Microalbuminuria; Nephelometry

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; INTERMETHOD COMPARISON; KIDNEY FAILURE; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NEPHELOMETRY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PRIMARY MEDICAL CARE; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; RELIABILITY; SCREENING TEST; SENSITIVITY AND SPECIFICITY; URINALYSIS; VALIDATION STUDY;

AGED; ALBUMINURIA; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERTENSION; MALE; MASS SCREENING; MICROCHEMISTRY; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; PREDICTIVE VALUE OF TESTS; REAGENT STRIPS; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 33748286849     PISSN: 00348376     EISSN: 00348376     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984; 310: 356-60.
2. Ruilope LM, Rodicio JL. The kidney and arterial hypertension. Nephrol Dial Transplant 2001; 16: 50-2.
3. Messent JW, Elliot TG, Hill RG, Jarrett RJ, Keen H, Viberti GC. Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three-year follow-up study. Kidney Int 1992; 41: 836-9.
4. Mogensen CE. Natural history of cardiovascular and renal disease in patients with type 2 diabetes: effect of therapeutic interventions and risk modification. Am J Cardiol 1998; 82: 4R-7R.
5. The National Kidney Foundation -K/DOQI guidelines. http://www.kidney.org
6. Rossert JA, Wauters JP. Recommendations for the screening and management of patients with chronic kidney disease. Nephrol Dial Transplant 2002; 17(1): 19-28.
7. Keane WF, Eknoyan G. Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): A position paper of National Kidney Foundation. Am J Kidney Dis 1999; 33: 1004-10.
8. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Lancet 1998; 2: 530-3.
9. Ismail N, Becker B, Strzelczyk P, Ritz E. Renal disease and hypertension in non insulin-dependent diabetes mellitus. Kidney Int 1999; 55: 1-28.
10. Kutter D, Thoma J, Kremer A, Hansen S, Carl R. Screening for oligoalbuminuria by micral-test II a new inmunological test strip. Eur J Clin Chem Clin Biochem 1995; 33: 243-5.
11. Tiu SC, Lee SS, Cheng MW. Comparison of six commercial techniques in the measurement of microalbuminuria in diabetic patients. Diabetes Care 1993; 16: 616-20.
12. Velazquez-Monroy O, Rosas Peralta M, Lara Esqueda A, et al. Prevalence and interrelations of noncommunicable chronic diseases and cardiovascular risk factors in México. Arch Cardiol Mex 2003; 73: 62-77.
13. Velazquez-Monroy O, Rosas Peralta M, Lara Esqueda A, et al. Hipertensión arterial en México: Resultados de la Encuesta Nacional de Salud (ENSA) 2000. Arch Cardiol Mex 2002; 72: 71-84.
14. United States Renal Data System: http://www.usrds.org
15. Breien AH, García BH, García GG, Gómez NB, Hernández RI, Lomelí AM, Monteón RF, Palomeque M, Ruiz MN. Epidemiología de la Insuficiencia Renal Crónica en Jalisco. Boletín del Colegio Jalisciense de Nefrología, A.C. 2001; 5: 6-7.
16. Martínez-Ramírez HR, Jalomo-Martínez B, Cortés-Sanabria L, Rojas-Campos E, Barragán G, Alfaro G, Cueto Manzano AM. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: A comparative prospective cohort study between primary health-care doctors and nephrologist. Am J Kidney Dis 2006 (in press).
17. Cueto-Manzano AM, Cortés-Sanabria L, Martínez-Ramírez HR, Rojas-Campos E, Barragán G, Alfaro G, Flores J, et al. Detection of early nephropathy in Mexican type 2 diabetes mellitus patients. Kidney Int 2005; 68 (Suppl. 97): S40-S45.
18. González VC, Stern MP, Arredondo PB, Martínez DS, Islas AS, Revilla C, González VM, Rivera MD. Nephropathy in low income diabetics: The Mexico City diabetes study. Arch Med Res 1996; 27: 367-73.
19. American Diabetes Association: Clinical Practice Recommendations 2001. Diabetes Care 2001; 24(1): S69-S72.
20. Chobanian AV, Barkis HL, Cushman WC, Green LA, Izzo JL, Jones DW, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-52.
21. Pegorado A, Singh A, Bakir A, Arruda JAL, Dunea G. Simplified screening for microalbuminuria. Ann Intern Med 1997; 127: 817-19.
22. Gerber LM, Johnston K, Alderman HM. Assessment of a new dipstick test in screening for microalbuminuria in patients with hypertension. Am J Hypertension 1998; 11: 1321-7.
23. Gilbert R, Akdeniz A, Jerums G. Detection of microalbuminuria in diabetic patients by urinary dipstick. Diabetes Res Clin Practice 1997; 35: 57-60.
24. Minetti EE, Cozzi MG, Granata S, Guidi E. Accuracy of the urinary albumin tritator stick "Micral-Test" in kidney disease patients. Nephrol Dial Transplant 1997; 12: 78-80.
25. Fernández F, Páez PJM, Hermosín BT, Vazquez GP, Ortiz CMA, Tarilonte DMA. Rapid screening test evaluation for microalbuminuria in diabetes mellitus. Acta Diabetol 1998; 35: 199-202.
26. Pouslen PL, Mogensen CE. Evaluation of a new semiquantitative stick for microalbuminuria. Diabetes Care 1995: 18: 732-3.
27. Mogensen CE, Viberti GC, Peheim E, Kutter D, Hasslacher C, Hofmann W, et al. Multicenter evaluation of the micraltest II test strip, an inmunologic rapid test for the detection of microalbuminuria. Diabetes Care 1997; 20: 1642-6.
28. Calzada-León R, Altamirano-Bustamante N, Robles-Valdés C, Franco-Rodríguez A, Franco-Betancur H, Jiménez C, et al. Sensibilidad y especificidad de la determinación cuantitativa de microalbuminuria para el diagnóstico de nefropatía diabética. Bol Med Hosp Infant Mex 1994; 51: 174-8.
29. Poulsen PL. Office tests for microalbuminuria. In: Mogensen CE (Ed.). The kidney and hypertension in diabetes mellitus. Third edition. Kluwer Academic Publishers, Norwell; 1997, pp. 127-34.
30. Mogensen CE. Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int 1987; 31: 673-89.
31. Keane WF. Proteinuria: Its clinical importance and role in progressive renal disease. Am J Kidney Dis 2000; 35(1): S97-S105.
32. Pedrinelli R. Microalbuminuria in essential hypertension. A marker of systemic vascular damage. Nephrol Dial Transplant 1997; 12: 379-98.
33. Weinstock BW, Keane WF. Proteinuria and cardiovascular disease. Am J Kidney Dis 2001; 38 (1): S8-S13.
34. Hebert LA, Wilmer WA, Falkenhain ME, Ladson-Wofford SE, Nahman NS, Rovin BH. Renoprotection: One or many therapies? Kidney Int 2001; 59: 1211-26.
35. Jungers P. Late referral: loss of chance for the patient, loss of money for society. Nephrol Dial Transplant 2002; 17: 371-5.